{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:49:08Z","timestamp":1793836148452,"version":"4.6.1"},"reference-count":137,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:00:00Z","timestamp":1544400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,18]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Systemic sclerosis (SSc) is an idiopathic systemic autoimmune disease. It is characterized by a triad of hallmarks: immune dysfunction, fibrosis and vasculopathy. Immune dysfunction in SSc is characterized by the activation and recruitment of immune cells and the production of autoantibodies and cytokines. How immune abnormalities link the fibrosis and vasculopathy in SSc is poorly understood. A plethora of immune cell types are implicated in the immunopathogenesis of SSc, including T cells, B cells, dendritic cells, mast cells and macrophages. How these different cell types interact to contribute to SSc is complicated, and can involve cell-to-cell interactions and communication via cytokines, including transforming growth factor (TGF)-\u03b2, interleukin (IL)-6 and IL-4. We will attempt to review significant and recent research demonstrating the importance of immune cell regulation in the immunopathogenesis of SSc with a particular focus on fibrosis.<\/jats:p>","DOI":"10.1111\/cei.13238","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T05:29:06Z","timestamp":1542259746000},"page":"310-321","source":"Crossref","is-referenced-by-count":187,"title":["The immunopathogenesis of fibrosis in systemic sclerosis"],"prefix":"10.1093","volume":"195","author":[{"given":"M","family":"Brown","sequence":"first","affiliation":[{"name":"Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"2021121023225942600_cei13238-bib-0001","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin Immunopathol"},{"key":"2021121023225942600_cei13238-bib-0002","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1523-1747.2001.00217.x","article-title":"Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes","volume":"116","author":"McGaha","year":"2001","journal-title":"J Invest Dermatol"},{"key":"2021121023225942600_cei13238-bib-0003","first-page":"823","article-title":"Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents","volume":"37","author":"Fertin","year":"1991","journal-title":"Cell Mol Biol"},{"key":"2021121023225942600_cei13238-bib-0004","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1097-4652(199605)167:2<290::AID-JCP13>3.0.CO;2-C","article-title":"Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets","volume":"167","author":"Sempowski","year":"1996","journal-title":"J Cell Physiol"},{"key":"2021121023225942600_cei13238-bib-0005","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI116015","article-title":"Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4","volume":"90","author":"Postlethwaite","year":"1992","journal-title":"J Clin Invest"},{"key":"2021121023225942600_cei13238-bib-0006","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj3070673","article-title":"Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4","volume":"307","author":"Wegrowski","year":"1995","journal-title":"Biochem J"},{"key":"2021121023225942600_cei13238-bib-0007","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2619::AID-IMMU2619>3.0.CO;2-M","article-title":"Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma","volume":"28","author":"Ong","year":"1998","journal-title":"Eur J Immunol"},{"key":"2021121023225942600_cei13238-bib-0008","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.11080","article-title":"Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients","volume":"48","author":"Luzina","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0010","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J Rheumatol"},{"key":"2021121023225942600_cei13238-bib-0011","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/CDLI.6.5.660-664.1999","article-title":"Increased levels of alternatively spliced interleukin 4 (IL-4delta2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis","volume":"6","author":"Sakkas","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"2021121023225942600_cei13238-bib-0012","first-page":"325","article-title":"The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma","volume":"50","author":"Ihn","year":"2002","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2021121023225942600_cei13238-bib-0013","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.febslet.2012.03.063","article-title":"Dynamics of TGF-beta\/Smad signaling","volume":"586","author":"Zi","year":"2012","journal-title":"FEBS Lett"},{"key":"2021121023225942600_cei13238-bib-0014","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1523-1747.2002.01719.x","article-title":"Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts","volume":"118","author":"Sato","year":"2002","journal-title":"J Invest Dermatol"},{"key":"2021121023225942600_cei13238-bib-0015","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/emboj\/18.5.1345","article-title":"TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway","volume":"18","author":"Hocevar","year":"1999","journal-title":"EMBO J"},{"key":"2021121023225942600_cei13238-bib-0016","doi-asserted-by":"crossref","first-page":"34634","DOI":"10.1074\/jbc.C000175200","article-title":"Activation of extracellular signal-regulated kinase 1\/2 inhibits type I collagen expression by human skin fibroblasts","volume":"275","author":"Reunanen","year":"2000","journal-title":"J Biol Chem"},{"key":"2021121023225942600_cei13238-bib-0017","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000163802","article-title":"In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease","volume":"61","author":"Koch","year":"1993","journal-title":"Pathobiology"},{"key":"2021121023225942600_cei13238-bib-0018","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","article-title":"Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis","volume":"27","author":"Sato","year":"2001","journal-title":"J Dermatol Sci"},{"key":"2021121023225942600_cei13238-bib-0019","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4419-6612-4_15","article-title":"Pathogenic role of IL-6 combined with TNF-alpha or IL-1 in the induction of acute phase proteins SAA and CRP in chronic inflammatory diseases","volume":"691","author":"Yoshizaki","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"2021121023225942600_cei13238-bib-0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2007-0299OC","article-title":"Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice","volume":"38","author":"Saito","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2021121023225942600_cei13238-bib-0021","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1074\/jbc.M113.545822","article-title":"Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-beta (TGF-beta) signaling promoting SMAD3 activation and fibrosis via Gremlin protein","volume":"289","author":"O\u2019Reilly","year":"2014","journal-title":"J Biol Chem"},{"key":"2021121023225942600_cei13238-bib-0022","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2018.08.003","article-title":"Targeting TLRs and the inflammasome in systemic sclerosis","volume":"192","author":"Henderson","year":"2018","journal-title":"Pharmacol Ther"},{"key":"2021121023225942600_cei13238-bib-0023","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2010.133587","article-title":"Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?","volume":"70","author":"Barnes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0024","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajpath.2011.09.013","article-title":"Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma","volume":"180","author":"Kitaba","year":"2012","journal-title":"Am J Pathol"},{"key":"2021121023225942600_cei13238-bib-0025","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/rheumatology\/keq275","article-title":"The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab","volume":"49","author":"Shima","year":"2010","journal-title":"Rheumatology (Oxf)"},{"key":"2021121023225942600_cei13238-bib-0026","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"2021121023225942600_cei13238-bib-0027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J Pathol"},{"key":"2021121023225942600_cei13238-bib-0028","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.1780340913","article-title":"Expression and function of surface antigens on scleroderma fibroblasts","volume":"34","author":"Abraham","year":"1991","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0029","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature12614","article-title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma","volume":"503","author":"Gerber","year":"2013","journal-title":"Nature"},{"key":"2021121023225942600_cei13238-bib-0031","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1136\/annrheumdis-2015-208213","article-title":"Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis","volume":"75","author":"Ponsoye","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0032","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-018-0020-8","article-title":"Regulatory mechanisms in T cell receptor signalling","volume":"18","author":"Gaud","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2021121023225942600_cei13238-bib-0033","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.semarthrit.2016.08.018","article-title":"Early- and late-stage morphea subtypes with deep tissue involvement is treatable with Abatacept (Orencia)","volume":"46","author":"Adeeb","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0034","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O'Reilly","year":"2012","journal-title":"Rheumatology (Oxf)"},{"key":"2021121023225942600_cei13238-bib-0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1164\/ajrccm.154.1.8680680","article-title":"The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury","volume":"154","author":"Sharma","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2021121023225942600_cei13238-bib-0036","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1073\/pnas.052709999","article-title":"Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts","volume":"99","author":"Kodera","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021121023225942600_cei13238-bib-0037","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.4049\/jimmunol.160.12.5719","article-title":"Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production","volume":"160","author":"Seder","year":"1998","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0038","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","article-title":"Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis","volume":"56","author":"Parel","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0039","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.4049\/jimmunol.150.6.2112","article-title":"Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells","volume":"150","author":"Gross","year":"1993","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0040","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4049\/jimmunol.164.5.2585","article-title":"Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent","volume":"164","author":"Fallon","year":"2000","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0041","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3565(24)35380-7","article-title":"Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts","volume":"292","author":"Oriente","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"2021121023225942600_cei13238-bib-0042","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1165\/rcmb.2002-0009OC","article-title":"Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis","volume":"27","author":"Belperio","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2021121023225942600_cei13238-bib-0043","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-015-0708-0","article-title":"Transforming growth factor-beta increases interleukin-13 synthesis via GATA-3 transcription factor in T-lymphocytes from patients with systemic sclerosis","volume":"17","author":"Baraut","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2021121023225942600_cei13238-bib-0044","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.24432","article-title":"Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis","volume":"60","author":"Fuschiotti","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0045","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jid.2016.11.037","article-title":"Skin-resident effector memory CD8(+)CD28(\u2013) T cells exhibit a profibrotic phenotype in patients with systemic sclerosis","volume":"137","author":"Li","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2021121023225942600_cei13238-bib-0046","doi-asserted-by":"crossref","first-page":"25066","DOI":"10.1038\/srep25066","article-title":"IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics","volume":"6","author":"OReilly","year":"2016","journal-title":"Sci Rep"},{"key":"2021121023225942600_cei13238-bib-0047","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cei.13045","article-title":"Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor alpha in normal and scleroderma dermal fibroblasts through protein kinase B\/Akt","volume":"191","author":"Brown Lobbins","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"2021121023225942600_cei13238-bib-0048","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0049","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0050","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2021121023225942600_cei13238-bib-0051","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2017.09.007","article-title":"Is there a role for IL-17 in the pathogenesis of systemic sclerosis?","volume":"195","author":"Chizzolini","year":"2018","journal-title":"Immunol Lett"},{"key":"2021121023225942600_cei13238-bib-0052","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2021121023225942600_cei13238-bib-0053","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1756-185X.12290","article-title":"Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis","volume":"17","author":"Olewicz-Gawlik","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0054","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar4334","article-title":"Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts","volume":"15","author":"Brembilla","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2021121023225942600_cei13238-bib-0055","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0056","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116525","article-title":"Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma","volume":"70","author":"Klein","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0057","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5493\/wjem.v7.i3.84","article-title":"Treg\/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients","volume":"7","author":"Krasimirova","year":"2017","journal-title":"World J Exp Med"},{"key":"2021121023225942600_cei13238-bib-0058","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00296-018-4071-8","article-title":"Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis","volume":"38","author":"Tang","year":"2018","journal-title":"Rheumatol Int"},{"key":"2021121023225942600_cei13238-bib-0059","doi-asserted-by":"crossref","first-page":"e0183102","DOI":"10.1371\/journal.pone.0183102","article-title":"Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis","volume":"12","author":"Manetti","year":"2017","journal-title":"PLOS ONE"},{"key":"2021121023225942600_cei13238-bib-0060","first-page":"930","article-title":"Changes in circulating monocytes in patients with progressive systemic sclerosis","volume":"14","author":"Andrews","year":"1987","journal-title":"J Rheumatol"},{"key":"2021121023225942600_cei13238-bib-0061","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2021121023225942600_cei13238-bib-0062","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-015-0554-8","article-title":"Macrophage involvement in systemic sclerosis: do we need more evidence?","volume":"18","author":"Stifano","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"2021121023225942600_cei13238-bib-0063","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2478\/v10039-012-0076-9","article-title":"Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis","volume":"58","author":"Bielecki","year":"2013","journal-title":"Adv Med Sci"},{"key":"2021121023225942600_cei13238-bib-0064","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1684\/ejd.2012.1756","article-title":"CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus","volume":"22","author":"Nakayama","year":"2012","journal-title":"Eur J Dermatol"},{"key":"2021121023225942600_cei13238-bib-0065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10067-012-1972-x","article-title":"Increased serum levels of soluble CD163 in patients with scleroderma","volume":"31","author":"Shimizu","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2021121023225942600_cei13238-bib-0066","doi-asserted-by":"crossref","first-page":"8509583","DOI":"10.1155\/2018\/8509583","article-title":"Soluble CD163 as a potential biomarker in systemic sclerosis","volume":"2018","author":"Frantz","year":"2018","journal-title":"Dis Markers"},{"key":"2021121023225942600_cei13238-bib-0067","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.trsl.2007.12.010","article-title":"Identification of candidate genes in scleroderma-related pulmonary arterial hypertension","volume":"151","author":"Grigoryev","year":"2008","journal-title":"Transl Res"},{"key":"2021121023225942600_cei13238-bib-0068","doi-asserted-by":"crossref","first-page":"e12106","DOI":"10.1371\/journal.pone.0012106","article-title":"Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury","volume":"5","author":"Pendergrass","year":"2010","journal-title":"PLOS ONE"},{"key":"2021121023225942600_cei13238-bib-0069","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.30318","article-title":"Interferon and alternative activation of monocyte\/macrophages in systemic sclerosis-associated pulmonary arterial hypertension","volume":"63","author":"Christmann","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0070","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"key":"2021121023225942600_cei13238-bib-0071","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-beta\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem Biol Interact"},{"key":"2021121023225942600_cei13238-bib-0072","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/art.30159","article-title":"Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension","volume":"63","author":"Hsu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0073","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of Interferon- and transforming growth factor beta-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021121023225942600_cei13238-bib-0074","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13073-017-0417-1","article-title":"A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis","volume":"9","author":"Taroni","year":"2017","journal-title":"Genome Med"},{"key":"2021121023225942600_cei13238-bib-0075","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1136\/annrheumdis-2016-210823","article-title":"Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis","volume":"76","author":"Huang","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0076","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/annrheumdis-2012-202814","article-title":"Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin","volume":"73","author":"Mathes","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0077","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO;2-S","article-title":"Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis","volume":"44","author":"Distler","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0078","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/1521-4141(2001010)31:10<2936::AID-IMMU2936>3.0.CO;2-0","article-title":"High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts","volume":"31","author":"Yamamoto","year":"2001","journal-title":"Eur J Immunol"},{"key":"2021121023225942600_cei13238-bib-0079","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2249.1999.00929.x","article-title":"Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis","volume":"117","author":"Hasegawa","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2021121023225942600_cei13238-bib-0080","first-page":"1202","article-title":"Macrophage infiltration in the skin of patients with systemic sclerosis","volume":"19","author":"Ishikawa","year":"1992","journal-title":"J Rheumatol"},{"key":"2021121023225942600_cei13238-bib-0081","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.imlet.2017.09.001","article-title":"Toll like receptors in systemic sclerosis: an emerging target","volume":"195","author":"O\u2019Reilly","year":"2018","journal-title":"Immunol Lett"},{"key":"2021121023225942600_cei13238-bib-0082","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","article-title":"Role of innate immune system in systemic sclerosis","volume":"37","author":"Fullard","year":"2015","journal-title":"Semin Immunopathol"},{"key":"2021121023225942600_cei13238-bib-0083","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2012-201958","article-title":"Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors","volume":"72","author":"Ciechomska","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0084","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/annrheumdis-2016-210189","article-title":"Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages","volume":"76","author":"Maier","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0085","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2146\/ajhp070449","article-title":"Tocilizumab: the first interleukin-6-receptor inhibitor","volume":"65","author":"Sebba","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"2021121023225942600_cei13238-bib-0086","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.4049\/jimmunol.181.10.7243","article-title":"Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis","volume":"181","author":"Mozaffarian","year":"2008","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0087","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1165\/ajrcmb.18.1.2627","article-title":"Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung","volume":"18","author":"Hancock","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2021121023225942600_cei13238-bib-0088","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar4352","article-title":"B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis","volume":"15","author":"Francois","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2021121023225942600_cei13238-bib-0089","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2021121023225942600_cei13238-bib-0091","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0092","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/sj.jid.5700919","article-title":"BAFF antagonist attenuates the development of skin fibrosis in tight-skin mice","volume":"127","author":"Matsushita","year":"2007","journal-title":"J Invest Dermatol"},{"key":"2021121023225942600_cei13238-bib-0093","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.185.3.461","article-title":"Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells","volume":"185","author":"Rincon","year":"1997","journal-title":"J Exp Med"},{"key":"2021121023225942600_cei13238-bib-0094","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"2021121023225942600_cei13238-bib-0095","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"2021121023225942600_cei13238-bib-0096","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/kev331","article-title":"Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity","volume":"55","author":"Matsushita","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2021121023225942600_cei13238-bib-0097","doi-asserted-by":"crossref","first-page":"eaas9944","DOI":"10.1126\/sciadv.aas9944","article-title":"BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance","volume":"4","author":"Matsushita","year":"2018","journal-title":"Sci Adv"},{"key":"2021121023225942600_cei13238-bib-0098","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood-2012-11-465658","article-title":"Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease","volume":"121","author":"Le Huu","year":"2013","journal-title":"Blood"},{"key":"2021121023225942600_cei13238-bib-0099","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity","volume":"165","author":"Sato","year":"2000","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0100","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.4049\/jimmunol.157.10.4371","article-title":"CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity","volume":"157","author":"Sato","year":"1996","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0101","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.molimm.2004.06.025","article-title":"Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis","volume":"41","author":"Sato","year":"2004","journal-title":"Mol Immunol"},{"key":"2021121023225942600_cei13238-bib-0102","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9440(10)63328-7","article-title":"B Lymphocyte signaling established by the CD19\/CD22 loop regulates autoimmunity in the tight-skin mouse","volume":"165","author":"Asano","year":"2004","journal-title":"Am J Pathol"},{"key":"2021121023225942600_cei13238-bib-0103","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"2021121023225942600_cei13238-bib-0104","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","article-title":"CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma","volume":"172","author":"Yoshizaki","year":"2008","journal-title":"Am J Pathol"},{"key":"2021121023225942600_cei13238-bib-0105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/art.1780390713","article-title":"Early expression of E-selectin, tumor necrosis factor alpha, and mast cell infiltration in the salivary glands of patients with systemic sclerosis","volume":"39","author":"Hebbar","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12948-016-0050-3","article-title":"Mastocytosis and systemic sclerosis: a clinical association","volume":"14","author":"Bagnato","year":"2016","journal-title":"Clin Mol Allergy"},{"key":"2021121023225942600_cei13238-bib-0107","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.lpm.2012.10.014","article-title":"Telangiectasic mastocytosis with systemic sclerosis","volume":"42","author":"Frigui","year":"2013","journal-title":"Presse Med"},{"key":"2021121023225942600_cei13238-bib-0108","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jdermsci.2017.12.005","article-title":"Systemic sclerosis complicated with localized scleroderma-like lesions induced by Kobner phenomenon","volume":"89","author":"Saigusa","year":"2018","journal-title":"J Dermatol Sci"},{"key":"2021121023225942600_cei13238-bib-0109","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/art.1780331114","article-title":"Dermal mast cell degranulation in systemic sclerosis","volume":"33","author":"Seibold","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/art.30190","article-title":"Mast cells are a source of transforming growth factor beta in systemic sclerosis","volume":"63","author":"Hugle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0111","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.4049\/jimmunol.160.10.5053","article-title":"Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4","volume":"160","author":"Trautmann","year":"1998","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0112","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1136\/annrheumdis-2011-200809","article-title":"Cell-to-cell contact of activated mast cells with fibroblasts and lymphocytes in systemic sclerosis","volume":"71","author":"Hugle","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0113","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1172\/JCI99088","article-title":"PAI1 mediates fibroblast-mast cell interactions in skin fibrosis","volume":"128","author":"Pincha","year":"2018","journal-title":"J Clin Invest"},{"key":"2021121023225942600_cei13238-bib-0114","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1038\/ncomms11703","article-title":"Tenascin-C drives persistence of organ fibrosis","volume":"7","author":"Bhattacharyya","year":"2016","journal-title":"Nat Commun"},{"key":"2021121023225942600_cei13238-bib-0115","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.1126\/scitranslmed.aam8458","article-title":"Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8","volume":"10","author":"Ah Kioon","year":"2018","journal-title":"Sci Transl Med"},{"key":"2021121023225942600_cei13238-bib-0116","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.imlet.2017.11.003","article-title":"Dendritic cells in systemic sclerosis: Advances from human and mice studies","volume":"195","author":"Affandi","year":"2018","journal-title":"Immunol Lett"},{"key":"2021121023225942600_cei13238-bib-0117","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"2021121023225942600_cei13238-bib-0118","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13075-016-1203-y","article-title":"Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease","volume":"18","author":"Volkmann","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2021121023225942600_cei13238-bib-0119","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98380","article-title":"pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis","volume":"3","author":"Kafaja","year":"2018","journal-title":"JCI Insight"},{"key":"2021121023225942600_cei13238-bib-0120","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cbin.10800","article-title":"Modulation of CD11c+ lung dendritic cells in respect to TGF-beta in experimental pulmonary fibrosis","volume":"41","author":"Chakraborty","year":"2017","journal-title":"Cell Biol Int"},{"key":"2021121023225942600_cei13238-bib-0121","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1042\/CS20170039","article-title":"MicroRNAs in the skin: role in development, homoeostasis and regeneration","volume":"131","author":"Horsburgh","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"2021121023225942600_cei13238-bib-0122","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/art.40163","article-title":"Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis","volume":"69","author":"Rossato","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021121023225942600_cei13238-bib-0123","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0889-857X(05)70297-0","article-title":"Antinuclear antibody in systemic sclerosis (scleroderma)","volume":"22","author":"Okano","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"2021121023225942600_cei13238-bib-0124","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/rheumatology\/40.10.1135","article-title":"Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis","volume":"40","author":"Sato","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"2021121023225942600_cei13238-bib-0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/08916934.2016.1230848","article-title":"Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis","volume":"49","author":"Mehta","year":"2016","journal-title":"Autoimmunity"},{"key":"2021121023225942600_cei13238-bib-0126","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.4049\/jimmunol.166.9.5456","article-title":"Distinct autoreactive T cell responses to native and fragmented DNA topoisomerase I: influence of APC type and IL-2","volume":"166","author":"Oriss","year":"2001","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0127","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20101629","article-title":"Platelet-derived serotonin links vascular disease and tissue fibrosis","volume":"208","author":"Dees","year":"2011","journal-title":"J Exp Med"},{"key":"2021121023225942600_cei13238-bib-0128","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.39817","article-title":"Platelets induce thymic stromal lymphopoietin production by endothelial cells: contribution to fibrosis in human systemic sclerosis","volume":"68","author":"Truchetet","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021121023225942600_cei13238-bib-0129","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.semarthrit.2017.05.004","article-title":"The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis","volume":"47","author":"Ntelis","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2021121023225942600_cei13238-bib-0130","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/rheumatology\/ker520","article-title":"Neutrophil-derived reactive oxygen species in SSc","volume":"51","author":"Barnes","year":"2012","journal-title":"Rheumatology (Oxf)"},{"key":"2021121023225942600_cei13238-bib-0131","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao3089","article-title":"Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis","volume":"10","author":"Maugeri","year":"2018","journal-title":"Sci Transl Med"},{"key":"2021121023225942600_cei13238-bib-0132","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12016-015-8505-8","article-title":"T and NK cell phenotypic abnormalities in systemic sclerosis: a cohort study and a comprehensive literature review","volume":"49","author":"Almeida","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"2021121023225942600_cei13238-bib-0133","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3389\/fimmu.2018.01665","article-title":"Natural killer cells exhibit a peculiar phenotypic profile in systemic sclerosis and are potent inducers of endothelial microparticles release","volume":"9","author":"Benyamine","year":"2018","journal-title":"Front Immunol"},{"key":"2021121023225942600_cei13238-bib-0134","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.1501491","article-title":"CD4+ Group 1 innate lymphoid cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis","volume":"196","author":"Roan","year":"2016","journal-title":"J Immunol"},{"key":"2021121023225942600_cei13238-bib-0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/annrheumdis-2015-207388","article-title":"Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis","volume":"75","author":"Wohlfahrt","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021121023225942600_cei13238-bib-0136","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/imm.12260","article-title":"Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-kappaB","volume":"143","author":"O'Reilly","year":"2014","journal-title":"Immunology"},{"key":"2021121023225942600_cei13238-bib-0137","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.3389\/fimmu.2018.01865","article-title":"Interleukin-6 and type-I collagen production by systemic sclerosis fibroblasts are differentially regulated by interleukin-17A in the presence of transforming growth factor-beta 1","volume":"9","author":"Dufour","year":"2018","journal-title":"Front Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13238","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13238","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13238","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/195\/3\/310\/41638242\/cei13238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/195\/3\/310\/41638242\/cei13238.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T02:21:16Z","timestamp":1775269276000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/195\/3\/310\/6403617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,10]]},"references-count":137,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,12,10]]},"published-print":{"date-parts":[[2019,2,18]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13238","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,12,10]]}}}